id: NEW:aud_medication_treatment_rate_to_alcohol_use_disorder
name: AUD Medication Treatment Rate â†’ Alcohol Use Disorder
from_node:
  node_id: NEW:aud_medication_treatment_rate
  node_name: AUD Medication Treatment Rate
to_node:
  node_id: alcohol_use_disorder
  node_name: Alcohol Use Disorder
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: AUD pharmacotherapy (naltrexone, acamprosate) is prescribed to patients in residential treatment'
- 'Step 2: Medications reduce alcohol craving and/or block rewarding effects of alcohol'
- 'Step 3: Reduced drinking and improved treatment outcomes during and after residential stay'
- 'Step 4: Decreased AUD severity and relapse rates'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Andrea K Finlay et al. 2017. "Barriers to and facilitators of pharmacotherapy for
    alcohol use disorder in VA residential treatment programs.." https://doi.org/10.1016/j.jsat.2017.03.005
  supporting_citations:
  - Additional citations require full-text access - abstract references evidence supporting pharmacotherapy
    for AUD but does not cite specific studies
  doi: 10.1016/j.jsat.2017.03.005
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Evidence-based AUD pharmacotherapy reduces alcohol use disorder severity and improves treatment
  outcomes among patients in residential programs
spatial_variation:
  varies_by_geography: true
  variation_notes: Receipt of pharmacotherapy varies widely across VA residential programs, creating geographic
    disparities in treatment outcomes
structural_competency:
  equity_implications: This mechanism links structural barriers to health outcomes. Veterans in VA residential
    treatment represent a severe AUD population requiring intensive care; structural barriers to pharmacotherapy
    create inequitable outcomes. Military veterans face elevated AUD prevalence, making structural facilitators
    particularly important for this population.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.275346'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
